|
@JimGreenwood | |||||
|
During #BiotechShowcase at #JPM20, I discussed BIO's commitment to capping out-of-pocket costs for patients in Part D. The truth is, short-sighed policies currently in front of Congress will stifle innovation and do little to help seniors better afford the medicines they need. pic.twitter.com/bcuHlQdiAz
|
||||||
|
||||||